» Articles » PMID: 33156085

Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy

Overview
Specialty Gastroenterology
Date 2020 Nov 6
PMID 33156085
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications.

Wu J, Zhao X, Ren B, Duan X, Sun J Int J Mol Sci. 2025; 26(5).

PMID: 40076465 PMC: 11899467. DOI: 10.3390/ijms26051839.


Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.

Chen J, Jin Z, Zhong B, Fan W, Zhang W, Luo B United European Gastroenterol J. 2024; 12(2):226-239.

PMID: 38372444 PMC: 10954431. DOI: 10.1002/ueg2.12554.


Transarterial Radioembolization for Management of Hepatocellular Carcinoma.

Badar W, Yu Q, Patel M, Ahmed O Oncologist. 2023; 29(2):117-122.

PMID: 38128565 PMC: 10836303. DOI: 10.1093/oncolo/oyad327.


External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Li H, Wu Z, Chen J, Su K, Guo L, Xu K Clin Exp Med. 2022; 23(5):1537-1549.

PMID: 36495367 PMC: 10460724. DOI: 10.1007/s10238-022-00972-4.


Current Imaging Diagnosis of Hepatocellular Carcinoma.

Chartampilas E, Rafailidis V, Georgopoulou V, Kalarakis G, Hatzidakis A, Prassopoulos P Cancers (Basel). 2022; 14(16).

PMID: 36010991 PMC: 9406360. DOI: 10.3390/cancers14163997.